Concepedia

Hiroshi Yasui

HY

71

Publications

6K

Citations

35

H-Index

1978

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Sapporo Medical University

The University of Tokyo

Tokyo Women's Medical University

Hiroshi Yasui is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and cancer research.

ORCID

Top concepts

Publications per year

1978–2023

71

Publications

71

A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib

Dharminder Chauhan, Laurence Catley, Guilan Li et al. · Cancer Cell · 2005 · 695 citations · Full text

, , +9

Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells

Teru Hideshima, Laurence Catley, Hiroshi Yasui et al. · Blood · 2006 · 420 citations · Full text

Molecular mechanisms whereby immunomodulatory drugs activate natural killer cells: clinical application

Toshiaki Hayashi, Teru Hideshima, Masaharu Akiyama et al. · British Journal of Haematology · 2004 · 316 citations

Bortezomib Mediates Antiangiogenesis in Multiple Myeloma via Direct and Indirect Effects on Endothelial Cells

Aldo M. Roccaro, Teru Hideshima, Noopur Raje et al. · Cancer Research · 2006 · 284 citations

Nuclear Export of Glucocorticoid Receptor is Enhanced by c-Jun N-Terminal Kinase-Mediated Phosphorylation

Motoyuki Itoh, M Adachi, Hiroshi Yasui et al. · Molecular Endocrinology · 2002 · 233 citations · Full text

, , +14

Rows per page

1–5 of 71